Business
– Teva is battling generic versions of the 20 mg and 40 mg dosages of its MS blockbuster. – In the absence of...
Hi, what are you looking for?
– Teva is battling generic versions of the 20 mg and 40 mg dosages of its MS blockbuster. – In the absence of...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has recalled a batch of its generic Parkinson’s combination drug treatment carbidopa/levodopa because of concern that...
– The Israeli biomedical company now faces competition for both of its drugs. – The share price of Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE:...
ElMindA, an Israeli company which has developed a helmet like device which covers the head and performs non-invasive brain scans has received approval from...
– – Gamida Cell’s main investors may sell all their holdings to Novartis at a later stage. – The deal for the sale...
People who have had heart attacks or who suffer from chronic heart conditions will soon be able to receive round the clock monitoring of...
– On CNBC’s Mad Dash, Cramer discussed the powerful performance of biotech stock Intercept (ICPT) which saw a 16.59% increase on Tuesday after strong...
– On Sunday, the NY Times reported that an unnamed Ebola vaccine has been added to the FDA’s Fast Track, and will be injected...
– Sales of the multiple sclerosis treatment were down 12% in the second quarter. – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) reported...
– Expanding Orthopedics, based in Or Akiva Industrial Park in Israel, is expanding the possibilities of orthopedic surgery with minimal invasiveness on news of...